Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Paul Meister
AddedFeb 13, 2024
UpdatedMay 31, 2026
Paul Meister

Paul Meister

Board Member, Amneal Pharmaceuticals

CrunchbaseThe Org

Paul Meister's Career

Amneal Pharmaceuticals
Amneal Pharmaceuticals

Bridgewater Township, NJ, US

Board Member· Board
Truvian
Truvian

San Diego, CA, US

Board Member· Board
Arbor Biotechnologies
Arbor Biotechnologies

Cambridge, MA, US

Board Member· Board
Syneos Health
Syneos Health

Morrisville, NC, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Paul Meister's Career

Amneal Pharmaceuticals
Amneal Pharmaceuticals
Public$3.2B7.6k2002Bridgewater Township, NJ, US
Board Member· Board

Leadership at Amneal Pharmaceuticals

Ted NarkTed NarkBoard Member
J Kevin BuchiJ Kevin BuchiBoard Member
Jeff GeorgeJeff GeorgeBoard Member
Shlomo YanaiShlomo YanaiBoard Member
Chintu PatelChintu PatelFounder
Kanu PatelKanu PatelBoard Member

Similar to Amneal Pharmaceuticals

Amphastar PharmaceuticalsAmphastar PharmaceuticalsRancho Cucamonga, CA, USBiologics, Pharmaceuticalsest. 1996Amphastar PharmaceuticalsRancho Cucamonga, CA, US · est. 1996

Amphastar Pharmaceuticals: A leading US-based specialty pharma company, expert in developing injectable and inhalation products.

Public · $300M1.6k
Meitheal PharmaceuticalsMeitheal PharmaceuticalsChicago, IL, USGeneric Medicineest. 2017Meitheal PharmaceuticalsChicago, IL, US · est. 2017

Meitheal Pharmaceuticals: Expert in research, production, and supply of generic injectable medicine.

Series D · $35M58
Eagle PharmaceuticalsEagle PharmaceuticalsWoodcliff Lake, NJ, USInjectables, Pharmaceuticalsest. 2007Eagle PharmaceuticalsWoodcliff Lake, NJ, US · est. 2007

Eagle Pharmaceuticals Inc.: A specialty pharma company, developing and distributing critical care and oncology injectables.

Public · $12.3M134
Masters PharmaceuticalMasters PharmaceuticalLebanon, NH, USPharmaceuticalsest. 2002Masters PharmaceuticalLebanon, NH, US · est. 2002

Masters Pharmaceutical: Quality-sourced wholesale provider of generic, branded, and OTC drugs.

Seed · $2.6M350
Truvian
Truvian
Series C$134.1M1282015San Diego, CA, US
Board Member· Board

Leadership at Truvian

Jean-Pierre MillonJean-Pierre MillonBoard Member
Kim KamdarKim KamdarBoard Member
Randal (Randy) ErmanRandal (Randy) ErmanCo-Founder
Megh GuptaMegh GuptaBoard Member
Ashok KrishnamurthiAshok KrishnamurthiBoard Member
Jay SrinivasanJay SrinivasanCEO
Arbor Biotechnologies
Arbor Biotechnologies
Series B$230.6M1702016Cambridge, MA, US
Board Member· Board

Leadership at Arbor Biotechnologies

David ScottDavid ScottCo-Founder
Keith CrandellKeith CrandellBoard Member
Feng ZhangFeng ZhangCo-Founder
Chen YuChen YuBoard Member
Winston YanWinston YanCo-Founder
Devyn SmithDevyn SmithCEO
Syneos Health
Syneos Health
Public$999.6M29.4k1998Morrisville, NC, US
Board Member· Board

Leadership at Syneos Health

Jim MomtazeeJim MomtazeeBoard Member
Colin ShannonColin ShannonBoard Member
John DineenJohn DineenBoard Member
Linda HartyLinda HartyBoard Member
Michael BellMichael BellBoard Member
Alfonso ZuluetaAlfonso ZuluetaBoard Member

Similar to Syneos Health

QuintilesQuintilesDurham, NC, USDrug Developmentest. 1982QuintilesDurham, NC, US · est. 1982

Quintiles: Outsourcing biopharmaceutical development and commercial services for innovative therapies.

Public · $3.5B10k
SyapseSyapseSan Francisco, CA, USReal-World Evidenceest. 2008SyapseSan Francisco, CA, US · est. 2008

Syapse: Advancing real-world care to alleviate serious disease burden with evidence-based solutions.

Public · $222.6M147
IQVIAIQVIADurham, NC, USHealthcare Dataest. 1954IQVIADurham, NC, US · est. 1954

Healthcare technology company in Danbury, CT.

Public · $1.5B87k
MedpaceMedpaceCincinnati, OH, USClinical Researchest. 1992MedpaceCincinnati, OH, US · est. 1992

Medpace, a global clinical research organization, accelerates the development of safe, effective medical therapeutics.

Public5.2k

Paul Meister's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Paul Meister

Michael A. MetzgerMichael A. MetzgerBoard Member · Northwell HealthJohn CiccioJohn CiccioBoard Member · OS TherapiesHenry B. SkinnerHenry B. SkinnerBoard Member · Quartet MedicineStephen McHaleStephen McHaleBoard Member · Axuall